A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of CBI-1214 T Cell Engager in Participants With Advanced or Metastatic MSS/MSI-L Colorectal Cancer

Name: A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of CBI-1214 T Cell Engager in Participants With Advanced or Metastatic MSS/MSI-L Colorectal Cancer
Published: 2026
License: Public Domain

Cartography Biosciences · 2026

ClinicalTrials.gov · Datasets · License: Public Domain · 2026

Open Source ↗

colon-cancer colorectal-cancer oncology

colorectal cancer, colorectal cancer (crc), colorectal (colon or rectal) cancer, crc, metastatic colon cancer, colon cancer, advanced colorectal cancer, oncology, solid tumor, phase 1, first-in-human, dose escalation

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 828851
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.